Randhawa Simrat
SEC CIK 1992260 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /DE/ | EVP, Head of R, D | 27.1K | $52.8K | $15.00M | 9 | 2023-09-21 | 2026-09-01 |
Most active insiders at DNTH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Garcia Marino | CEO AND Pres, Dir | — | $27.96M |
| 2 | Randhawa Simrat | EVP, Head of R, D | — | $15.00M |
| 3 | Savitz Ryan | EVP, CFO, CBO | — | $14.29M |
| 4 | CARR EDWARD | CAO | — | $5.59M |
| 5 | Veness Adam M | SVP, GC, Sec | — | $4.63M |
| 6 | Soteropoulos Paula | Dir | — | $2.25M |
| 7 | McGeorge Anne | Dir | — | $844.8K |
| 8 | Read Simon | Dir | — | $630.8K |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-03 16:30 | 2026-09-01 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | EVP, Head of R, D | M - OptEx | $20.63 | +23.1K | 27.1K | +578% | +$477.0K |
| DMT | 2026-09-03 16:30 | 2026-09-01 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | EVP, Head of R, D | S - Sale+OE | $106.41 | -23.1K | 4,000 | -85% | -$2.46M |
| DMT | 2026-06-02 19:00 | 2026-06-01 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | EVP, Head of R, D | M - OptEx | $18.85 | +26.5K | 30.5K | +663% | +$500.2K |
| DMT | 2026-06-02 19:00 | 2026-06-01 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | EVP, Head of R, D | S - Sale+OE | $90.62 | -26.5K | 4,000 | -87% | -$2.40M |
| DMT | 2026-03-13 | 2026-03-12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | EVP, Head of R, D | M - OptEx | $18.15 | +33.8K | 7,998 | New | +$614.2K |
| DT | 2026-03-13 | 2026-03-12 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | EVP, Head of R, D | S - Sale+OE | $81.48 | -33.8K | 0 | -100% | -$2.76M |
| DMT | 2025-11-14 | 2025-11-13+ | DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | EVP, Head of R, D | M - OptEx | $15.25 | +196.5K | 91.5K | New | +$3.00M |
| DMT | 2025-11-14 | 2025-11-13+ | DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | EVP, Head of R, D | S - Sale+OE | $37.55 | -196.5K | 65.3K | -75% | -$7.38M |
| M | 2023-09-25 | 2023-09-21+ | DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | Chief Medical Off | P - Purchase | $13.20 | +4,000 | 4,000 | New | +$52.8K |
Purchase Sale Sale after option exercise All abbreviations